(Nanowerk News) Syringe-injectable biomaterials, medical devices and engineered tissues have attracted great attention as minimally-invasive implants for diagnosis, therapy and regenerative medicine.

Terumo Medical has announced the launch of its SurTract Safety Syringe in the US, incorporating Roncadelle Operations’ SafeR ...

Syringe-injectable biomaterials, medical devices and engineered tissues have attracted great attention as minimally-invasive implants for diagnosis, therapy and regenerative medicine. Free-standing ...

The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...

Terumo Medical Corporation, a wholly-owned subsidiary of Terumo Corporation, announced the US launch of its SurTract™ Safety Syringe, powered by SafeR® passive safety technology developed by ...

(MENAFN- GetNews) Mordor Intelligence has published a new report on sterile injectable drugs market offering a comprehensive analysis of trends, growth drivers, and future projections. Introduction ...

A new intervention could save lives, recognizing that adolescents are at higher risk for fatal food-allergic reactions. Researchers from the Icahn School of Medicine at Mount Sinai have found that ...

Please provide your email address to receive an email when new articles are posted on . Bone voids, or bone marrow lesions, and other bone defects of the skeletal system are typically non-traumatic, ...

The ultrathin films are able to be injected using minimally-invasive syringe needles and can be used as a platform to deliver molecular and cellular drugs. The use of shape-memory polymer also enables ...